Published in Ocular Surface

The Latest in Utilizing Scleral Lenses as Dry Eye Therapy

This is editorially independent content
13 min read

Learn how optometrists can use scleral lenses to manage dry eye disease, with tips for patient selection, setting expectations, and preventing midday fogging.

Image of an optometrist placing a scleral lens on a patient with dry eye.
According to TFOS DEWS III, “Dry eye is a multifactorial, symptomatic disease characterized by a loss of homeostasis of the tear film and/or ocular surface, in which tear film instability and hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities are etiological factors.”1
Dry eye disease (DED) symptoms include ocular dryness, grittiness, foreign body sensation, debilitating pain, photophobia, visual fluctuation, and visual distortion. Scleral lenses have become instrumental in the management of ocular surface disease (OSD).
They are well tolerated, highly effective for DED, and have consistently demonstrated the ability to improve both symptoms and visual acuity with minimal complications.2 Additionally, patient-reported outcomes show a significant positive impact on ocular comfort and quality of life with scleral lens wear.3

An overview of scleral lenses for DED

Multiple studies have shown improvements in dry eye symptoms for many indications, demonstrated by reductions in Ocular Surface Disease Index (OSDI) scores.4-8 According to the TFOS DEWS III Management and Therapy report, “Scleral contact lens use is generally not linked to specific complications and effectively improves the signs and symptoms of dry eye disease.”9
Since scleral lenses bathe and protect the ocular surface, they may be considered an advantageous option for individuals with all severities of DED, from mild to severe.
Figure 1: Corneal staining in severe dry eye disease.
Corneal staining in severe dry eye disease.
Figure 1: Courtesy of Jennifer Harthan, OD.
Figure 2: Scleral lens fit on an eye with severe dry eye.
Scleral lens fit on an eye with severe dry eye.
Figure 2: Courtesy of Nathan Schramm, OD.
Therapeutic indications for scleral lenses for OSD include:10-12
Figure 3: Filamentary keratitis before scleral lens fitting.
Filamentary keratitis before scleral lens fitting.
Figure 3: Courtesy of Caity Morrison, OD.
Figure 4: Filamentary keratitis after scleral lens management.
Filamentary keratitis after scleral lens management.
Figure 4: Courtesy of Caity Morrison, OD.

Benefits of scleral lenses

There are many unique advantages of fitting scleral lenses in dry eye disease, even in individuals with regular corneas. Scleral lenses may be especially beneficial for symptomatic soft contact lens wearers who struggle with dryness and discomfort. The post-lens fluid reservoir of scleral lenses creates a sealed, lubricating environment over the ocular surface, effectively eliminating tear film evaporation.13
Scleral lenses maintain a stable post-lens tear reservoir composed of preservative-free saline and components of the natural tears. This is unlike soft contact lenses, which can thin the lipid layer and increase evaporation.13
Dry eye is a multifactorial condition, and oftentimes aqueous-deficient and evaporative dry eye exist along a continuum. This continuous hydration makes scleral lenses potentially beneficial for all types of dry eye disease.15
Moreover, the scleral bowl can be utilized off-label as a delivery reservoir for therapeutic agents targeting OSD, such as cyclosporine, with the goal of increasing drug corneal contact time, increasing bioavailability, and potentially increasing efficacy compared to standard on-label application of topical ophthalmic drops.14

Research on using cyclosporine in the scleral lens reservoir

A pilot study evaluated the tolerability of scleral lens use as a delivery system for preservative-free cyclosporine 0.05% in individuals with dry eye disease.14 Fourteen established scleral lens wearers with a baseline OSDI of 13 or greater and a baseline corneal fluorescein staining of two or higher were enrolled.
One drop of cyclosporine 0.05% was placed in the lens reservoir along with preservative-free saline. Lenses were worn for 6 hours, removed, and the protocol was repeated for an additional 4 hours or more.
After 1 month, participants demonstrated improvements in ocular surface signs, including corneal and conjunctival staining and conjunctival hyperemia, along with a modest improvement in symptoms, while visual acuity remained unchanged.14
These findings suggest that scleral lens–based delivery of cyclosporine is well tolerated and potentially effective, though larger studies are needed to confirm efficacy and long-term outcomes.14
In addition, there is no contact lens dehydration related to scleral lens wear since scleral lenses are not hydrated.13 In contrast, soft contact lenses are prone to dehydration due to environmental factors, which may contribute to discomfort and dryness. By eliminating lens dehydration, scleral lenses remove a key contributor to contact lens–related dry eye symptoms.13

How scleral lenses provide improved comfort and stability of vision

Scleral lenses offer improved comfort and stability of vision since they avoid direct epithelial contact, vault the cornea, and reduce mechanical irritation associated with blinking.13 The stable optical surface can improve visual acuity and reduce fluctuations, which may enhance overall comfort and tolerance of lens wear compared to other lens modalities.

Corneal healing

Scleral lenses have the ability to support corneal healing by protecting the ocular surface and reducing epithelial stress. Studies and clinical surveys have demonstrated reductions in corneal staining after scleral lens wear, with particularly strong evidence in conditions such as neurotrophic keratitis and persistent epithelial defects.15,16
Figure 5: Scleral lens with lissamine green staining.
Scleral lens with lissamine green staining.
Figure 5: Courtesy of Nathan Schramm, OD.

Visual acuity

Scleral lenses can improve visual acuity and, in turn, improve overall contact lens comfort in individuals with dry eye disease. Soft contact lens research has shown that reduced visual acuity is associated with poorer perceived comfort.17,18
In contrast, scleral lenses have demonstrated improved best-corrected visual acuity compared to habitual correction (soft contact lenses or glasses), even in eyes with regular corneas.13
By creating a stable post-lens tear reservoir, scleral lenses can mask anterior corneal astigmatism and minor surface irregularities, resulting in a smoother refractive surface and thus more consistent vision. This improvement in visual quality may contribute to improved comfort during wear.
However, direct evidence linking improved visual acuity with enhanced comfort in scleral lens wear is limited. Additional scleral lens–specific research in dry eye populations is needed.13

Addressing midday fogging

Midday fogging (MDF) is one of the most frequent complications of scleral lens wear, affecting 26 to 46% of scleral lens wearers in general, and up to 75% of individuals with DED.19-21 MDF is when debris accumulates in the post-lens tear reservoir, causing blurred vision.22
Research suggests that inflammation plays a major role: inflammatory markers, including MMP-9, MMP-10, and neutrophils, are often elevated in the post-lens tear film of those with MDF.22 Since DED is inherently inflammatory, these individuals may be more prone to MDF and require proactive management of both ocular surface inflammation and lens parameters.20,23
Midday fogging is typically managed through a combination of strategies, including lens removal and reapplication once or twice daily, adjusting the scleral lens fit, including improving landing zone alignment or reducing fluid reservoir thickness, the use of more viscous application solutions, and treatment of underlying ocular surface disease, including allergies and dry eye disease.23

Pearls for filling solutions in scleral lenses

Additionally, a study demonstrated that using a filling solution designed to closely mimic the composition of natural tears resulted in statistically significant improvements in comfort and subjective visual quality compared with habitual filling solutions.23 Regularly reviewing filling and disinfection solutions at each visit is essential for successful scleral lens wear.
Preservative-free solutions are recommended for scleral lens filling. Different solutions vary in their properties, including buffered versus non-buffered formulations and the presence of electrolytes. Replacement after a single use is recommended. In some cases, combining these solutions with a more viscous agent in the lens reservoir may enhance comfort and visual stability, depending on the patient’s ocular surface needs.
A recent study evaluated the impact of using a high-viscosity sodium hyaluronate solution in the scleral lens fluid reservoir on post-lens fluid turbidity and lens settling.24 Scleral lenses were fitted in individuals with keratoconus, and visual performance and lens behavior were assessed.
The study concluded that high-viscosity sodium hyaluronate may improve low-contrast visual performance compared with saline, without adversely affecting post-lens fluid turbidity or scleral lens settling.24

When wettability is an issue

Individuals with DED often experience poor scleral lens surface wettability, likely due to meibomian gland dysfunction or excess lipid deposition.25
Figure 6: Significant surface debris on a scleral lens.
Significant surface debris on a scleral lens.
Figure 6: Courtesy of Melissa Barnett, OD.
Poor wettability results in unstable tear distribution on the lens surface, causing blurred vision, discomfort, and reduced lens tolerance.25 Clinically, the scleral lens surface may look “greasy” or irregular. Selecting appropriate lens materials, surface treatments (e.g., PEG coatings), and reviewing skincare or cosmetic products can help.
In a double-masked crossover study of 21 scleral lens wearers with dry eye and lens discomfort, polyethylene glycol (Hydra-PEG) surface-treated scleral lenses significantly improved comfort, dry eye symptoms, ocular surface signs, visual clarity, and comfortable wearing time compared with untreated lenses.26 Overall, PEG surface treatment reduced ocular surface compromise and enhanced the scleral lens wearing experience in individuals with dry eye disease.
Conventional management options for anterior scleral lens fogging are increased lubrication with preservative-free artificial tears throughout the day and removal, manual cleaning, rinsing, and reapplication of the lenses. Hydrogen peroxide-based solutions may offer additional benefits, especially for patients with dry eye or sensitivity to preservatives.

Managing patient expectations

Individuals with dry eye disease and regular corneas often report lower satisfaction with scleral lenses compared to those with corneal irregularities, due to factors such as more frequent midday fogging requiring lens removal, surface deposits that affect visual quality, conjunctival sensitivity not addressed by scleral lenses, and less dramatic visual improvement.15,25 These elements may reduce motivation to persist through the application and removal and adaptation periods.
Setting realistic expectations is essential for successful scleral lens wear. Numerous educational resources are available to support both practitioners and patients, including the Scleral Lens Education Society (SLS), Gas Permeable Lens Institute (GPLI), and Association of Contact Lens Educators (AOCLE), as well as manufacturer-provided brochures and digital educational materials.

Final thoughts

When fitting scleral lenses for dry eye disease, guidance from TFOS DEWS III reminds us that “multiple treatments used together are the likely and most appropriate management strategy, considering that DED has multiple pathogenic drivers.”9
Thus, it is essential to address all aspects of ocular surface disease concurrently. Within this multimodal approach, scleral lenses can provide significant benefits, including improved vision, enhanced comfort, and a significant improvement in quality of life.

Key takeaways

  1. Clearly explain the scleral lens fitting process.
  2. Establish realistic expectations regarding comfort, vision, and adaptation.
  3. Optimize the ocular surface prior to fitting to improve outcomes.
  4. Continue existing dry eye therapies when initiating scleral lens wear, with the potential to reduce treatments over time.
  5. Review proper lens application and disinfection solutions to support long-term success.
  1. Wolffsohn JS, Benítez-Del-Castillo JM, Loya-Garcia D, et al. TFOS DEWS III: Diagnostic Methodology. Am J Ophthalmol. 2025;279:387-450. doi:10.1016/j.ajo.2025.05.033
  2. Bavinger JC, DeLoss K, Mian SI. Scleral lens use in dry eye syndrome. Curr Opinion Ophthalmol. 2015 Jul;26:319-324.
  3. Hadimani SR, Kaur H, Shinde AJ, Chottopadhyay T. Quality of life and vision assessment with scleral lenses in keratoconus. Saudi J Ophthalmol. 2023 Oct 24;38:173-178.
  4. Chiu GB, Bach D, Theophanous C, Heur M. Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) scleral lens for Salzmann's nodular degeneration. Saudi J Ophthalmol. 2014 Jul;28:203-206.
  5. La Porta Weber S, Becco de Souza R, Gomes JAP, Hofling-Lima AL. The Use of the Esclera Scleral Contact Lens in the Treatment of Moderate to Severe Dry Eye Disease. Am J Ophthalmol. 2016 Mar;163:167-173.
  6. Bhattacharya P, Mahadevan R. Quality of life and handling experience with the PROSE device: an Indian scenario. Clin Exp Optom. 2017 Nov;100:710-717.
  7. Chahal JS, Heur M, Chiu GB. Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lens Therapy for Exposure Keratopathy. Eye Contact Lens. 2017 Jul;43:240-244.
  8. Serramito M, Privado-Aroco A, Batres L, Carracedo GG. Corneal surface wettability and tear film stability before and after scleral lens wear. Cont Lens Anterior Eye. 2019 Oct;42:520-525.
  9. Jones L, Craig JP, Markoulli M, et al. TFOS DEWS III: Management and Therapy. Am J Ophthalmol. 2025;279:289-386. doi:10.1016/j.ajo.2025.05.039
  10. Asghari B, Brocks D, Carrasquillo KG, Crowley E. OSDI Outcomes Based on Patient Demographic and Wear Patterns in Prosthetic Replacement of the Ocular Surface Ecosystem. Clin Optom (Auckl). 2022 Jan 10;14:1-12.
  11. Gomes JAP, Santo RM. The impact of dry eye disease treatment on patient satisfaction and quality of life: A review. Ocul Surf. 2019 Jan;17:9-19.
  12. Schornack M. Medical indications for scleral lens use. In Barnett M, Johns LK. Contemporary Scleral Lenses: Theory and Application. Bentham Science, 2017;4:143-166/
  13. Qiu SX, Fadel D, Hui A. Scleral Lenses for Managing Dry Eye Disease in the Absence of Corneal Irregularities: What Is the Current Evidence? J Clin Med. 2024 Jun 29;13(13):3838. doi: 10.3390/jcm13133838. PMID: 38999403; PMCID: PMC11242693.
  14. Barnett M, Courey C, Fadel D, et al. CLEAR – Scleral lenses. Cont Lens Anterior Eye. 2021;44(2):270-288.
  15. Nakhla MN, Patel R, Crowley E, et al. Utilizing PROSE as a drug delivery device for preservative-free cyclosporine 0.05% for the treatment of dry eye disease: A pilot study. Clin Ophthalmol. 2024;18:3203-3213.
  16. Schornack MM, Pyle J, Patel SV. Scleral lenses in the management of ocular surface disease. Ophthalmology. 2010;121(7):1398-1405.
  17. Maldonado-Codina C, Navascues Cornago M, Read ML, et al. The association of comfort and vision in soft toric contact lens wear. Contact Lens Anterior Eye 2021;44(4):101387.
  18. Diec, J.; Naduvilath, T.; Tilia, D.; Bakaraju, R.C.; Optom, B. The Relationship between Vision and Comfort in Contact Lens Wear. Eye Contact Lens 2021, 47, 271–276.
  19. Walker, M.K.; Bergmanson, J.P.; Miller, W.L.; Marsack, J.D.; Johnson, L.A. Complications and Fitting Challenges Associated with Scleral Contact Lenses: A Review. Contact Lens Anterior Eye 2016, 39, 88–96. [
  20. Postnikoff, C.K.; Pucker, A.D.; Laurent, J.; Huisingh, C.; McGwin, G.; Nichols, J.J. Identification of Leukocytes Associated with Midday Fogging in the Post-Lens Tear Film of Scleral Contact Lens Wearers. Investig. Ophthalmol. Vis. Sci. 2019, 60, 226–233.
  21. Schornack, M.M.; Fogt, J.; Harthan, J.; Nau, C.B.; Nau, A.; Cao, D.; Shorter, E. Factors Associated with Patient-Reported Midday Fogging in Established Scleral Lens Wearers. Contact Lens Anterior Eye 2020, 43, 602–608.
  22. Fogt JS. Midday fogging of scleral contact lenses: Current perspectives. Clin Optom. 2021;13:209-219.
  23. Walker, M.K.; Lema, C.; Redfern, R. Scleral Lens Wear: Measuring Inflammation in the Fluid Reservoir. Contact Lens Anterior Eye 2020, 43, 577–584.
  24. Vurgun EB, Ozkan G, Turhan SA, Toker AE. The effect of scleral lens reservoir solution on post-lens fluid turbidity and settling in patients keratoconus. Eye Contact Lens. 2025;51(12):529-535.
  25. Qiu SX, Fadel D, Hui A. Scleral lenses for managing dry eye disease in the absence of corneal irregularities: what is the current evidence?. J Clin Med. 2024;13(13):3838.
  26. Mickles CV, Harthan JS, Barnett M. Assessment of a novel lens surface treatment for scleral lens wearers with dry eye. Eye Contact Lens. 2021;47(5):308-313.
Melissa Barnett, OD, FAAO, FSLS, FBCLA
About Melissa Barnett, OD, FAAO, FSLS, FBCLA

Dr. Melissa Barnett is a principal optometrist at the University of California, Davis Eye Center in Sacramento and Davis, California. She is an internationally recognized key opinion leader, specializing in dry eye disease and specialty contact lenses. Dr. Barnett lectures and publishes extensively on topics including dry eye, anterior segment disease, contact lenses and creating a healthy balance between work and home life for women in optometry. She is a Fellow of the American Academy of Optometry, a Diplomate of the American Board of Certification in Medical Optometry, a Fellow of the British Contact Lens Association and serves on the Board of the American Optometric Association Contact Lens and Cornea Section, Gas Permeable Lens Institute, International Society of Contact Lens Specialists and is Past President of The Scleral Lens Education Society.

Drs. Melissa Barnett and Lynette Johns authored and edited the book Contemporary Scleral Lenses: Theory and Application with the unique perspectives and contributions of international experts. Dr. Barnett was awarded the inaugural Theia Award for Excellence for Mentoring by Women in Optometry. She was granted the Most Influential Women in Optical from Vision Monday in 2019.

In her spare time, she enjoys cooking, yoga, hiking and spending time with her family, Todd Erickson, also an optometrist, and two sons, Alex and Drew.

To learn more, visit her website at: www.drmelissabarnett.com

Melissa Barnett, OD, FAAO, FSLS, FBCLA
Eyes On Eyecare Site Sponsors
Astellas Logo